New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 26, 2019 - Shield Therapeutics announced the FDA approval of Accrufer (ferric maltol), for the treatment of iron deficiency in adults.
Download PDF
Return to publications
